TherapeuticsMD
TXMD
#10160
Rank
NZ$34.86 M
Marketcap
NZ$3.01
Share price
8.07%
Change (1 day)
40.61%
Change (1 year)

TherapeuticsMD (TXMD) - Net assets

Net assets on the balance sheet as of June 2025 : NZ$47.24 Million

According to TherapeuticsMD's latest financial reports the company has NZ$47.24 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

TherapeuticsMD - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$48.53 M4.79%
2023-12-31$NZ$46.31 M-16.33%
2022-12-31$NZ$55.35 M-140.38%
2021-12-31$-NZ$0.14 Billion-20.24%
2020-12-31$-NZ$0.18 Billion-1357.9%
2019-12-31$NZ$13.66 M-90.6%
2018-12-31$NZ$0.14 B-20.52%
2017-12-31$NZ$0.18 B-0.62%
2016-12-31$NZ$0.18 B99.75%
2015-12-31$NZ$92.14 M49.2%
2014-12-31$NZ$61.75 M-7.22%
2013-12-31$NZ$66.56 M-3920.8%
2012-12-31$-NZ$1.75 Million-20.58%
2011-12-31$-NZ$2.2 Million-275.46%
2010-12-31$NZ$1.25 M-391.9%
2009-12-31$-NZ$0.43 Million-1429.22%
2008-12-31$NZ$0.03 M-94.09%
2007-12-31$NZ$0.54 M-77.24%
2006-12-31$NZ$2.39 M24.55%
2005-12-31$NZ$1.92 M30.5%
2004-12-31$NZ$1.47 M10.59%
2003-12-31$NZ$1.33 M-5.31%
2002-12-31$NZ$1.4 M-13.06%
2001-12-31$NZ$1.61 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Agile Therapeutics
AGRX
-NZ$37.93 Million-180.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Lannett Company
LCI
-NZ$0.72 Billion-1,610.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$161.14 B 341,010.95%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-NZ$4.5 Billion-9,622.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
NZ$16.65 B 35,151.58%๐Ÿ‡ฌ๐Ÿ‡ง UK